These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 28723860

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin is significantly linked to azathioprine metabolite concentrations in Crohn's disease.
    Essmann J, Keil C, Unruh O, Otte A, Manns MP, Bachmann O.
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):99-108. PubMed ID: 30212402
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease.
    Poon SS, Asher R, Jackson R, Kneebone A, Collins P, Probert C, Dibb M, Subramanian S.
    J Crohns Colitis; 2015 Aug; 9(8):640-6. PubMed ID: 25968584
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA.
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK.
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1106-14. PubMed ID: 21929546
    [Abstract] [Full Text] [Related]

  • 10. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T.
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A, Tsujikawa T, Ban H, Hashimoto T, Bamba S, Ogawa A, Sasaki M, Saito Y, Fujiyama Y.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [Abstract] [Full Text] [Related]

  • 14. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
    Kreijne JE, Seinen ML, Wilhelm AJ, Bouma G, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
    [Abstract] [Full Text] [Related]

  • 15. Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.
    Luber RP, Dawson L, Munari S, Kariyawasam VC, Martin C, Gibson PR, Sparrow MP, Ward MG.
    J Gastroenterol Hepatol; 2021 Apr; 36(4):990-998. PubMed ID: 32881046
    [Abstract] [Full Text] [Related]

  • 16. Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease.
    Feng R, Guo J, Zhang SH, Qiu Y, Chen BL, He Y, Zeng ZR, Ben-Horin S, Chen MH, Mao R.
    J Gastroenterol Hepatol; 2019 Apr; 34(4):679-685. PubMed ID: 30175864
    [Abstract] [Full Text] [Related]

  • 17. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease.
    Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR.
    Inflamm Bowel Dis; 2011 Jun; 17(6):1301-7. PubMed ID: 20812329
    [Abstract] [Full Text] [Related]

  • 18. Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.
    Stocco G, Cuzzoni E, De Iudicibus S, Favretto D, Malusà N, Martelossi S, Pozzi E, Lionetti P, Ventura A, Decorti G.
    World J Gastroenterol; 2015 Mar 28; 21(12):3571-8. PubMed ID: 25834322
    [Abstract] [Full Text] [Related]

  • 19. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy.
    Bayoumy AB, Ansari AR, Mulder CJJ, Schmiegelow K, Florin T, De Boer NKH.
    Clin Pharmacokinet; 2024 Aug 28; 63(8):1089-1109. PubMed ID: 39031224
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb 28; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.